compounded semaglutide uk Novo Nordisk's Wegovy Weight Loss Pill Approved in the U.K Semaglutide for weight loss |

Actual prescribing guidelines will only be available once the medication is approved

June 2025 On June 6, 2025, the European Medicines Agencys (EMA) safety committee concluded that Novo Nordisks semaglutide-containing drugsincluding the popular weight-loss drug Wegovy and diabetes treatments Ozempic and Rybelsusmay cause rare but serious cases of non-arteritic anterior ischemic optic neuropathy (NAION), a sudden and painless vision loss in one eye due to optic nerve damage

Latiff, E

For individuals participating in a retatrutide clinical trial, the first point of contact for any new or worsening symptoms should be the trial investigator or clinical team, rather than self-managing independently